Hongmei Li
639 Longmian Avenue, 211198, PR China
Puerto Rico
Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Rational design of 4-((6-phenoxypyrimidin-4-yl)amino)-N-(4-(piperazin-1-yl)phenyl)-1H-pyrazole-3-carboxamide (LT-540-717) as orally bioavailable FLT3 inhibitor.
Journal: European journal of medicinal chemistry
Published: March 16, 2023
Wodyetia bifurcate structured carbon fabrics with durable superhydrophobicity for high-efficiency oil-water separation.
Journal: Journal of hazardous materials
Published: April 18, 2022
Discovery of 2H-benzo[b][1,4]oxazin-3(4H)-one derivatives as potent and selective CDK9 inhibitors that enable transient target engagement for the treatment of hematologic malignancies.
Journal: European journal of medicinal chemistry
Published: March 08, 2022
Development of a thermally stable Pt catalyst by redispersion between CeO2 and Al2O3.
Journal: RSC advances
Published: January 04, 2021
Design of a facile fluorescent probe with a large Stokes shift for hydrogen peroxide imaging in vitro and in vivo.
Journal: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Published: January 20, 2020
Discovery of novel small molecule induced selective degradation of the bromodomain and extra-terminal (BET) bromodomain protein BRD4 and BRD2 with cellular potencies.
Journal: Bioorganic & medicinal chemistry
Published: September 11, 2019
Combining structure- and property-based optimization to identify selective FLT3-ITD inhibitors with good antitumor efficacy in AML cell inoculated mouse xenograft model.
Journal: European journal of medicinal chemistry
Published: March 21, 2019
Discovery of a highly selective FLT3 inhibitor with specific proliferation inhibition against AML cells harboring FLT3-ITD mutation.
Journal: European journal of medicinal chemistry
Published: October 02, 2018
Discovery of the selective and efficacious inhibitors of FLT3 mutations.
Journal: European journal of medicinal chemistry
Published: February 06, 2018
ERK5/KLF2 activation is involved in the reducing effects of puerarin on monocyte adhesion to endothelial cells and atherosclerotic lesion in apolipoprotein E-deficient mice.
Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: November 29, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026